Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Meribank Biotech Co., Ltd (4724.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
0.00
P/B ratioShare price divided by book value per share.
0.84
P/S ratioMarket value divided by annual revenue.
2.41
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
34.99%
Operating marginRevenue left after operating costs.
-34.91%
Net marginRevenue left after every cost, including tax and interest.
-33.07%
Return on equityProfit as a percentage of shareholders’ equity.
-11.33%
Return on assetsProfit as a percentage of total assets.
-2.37%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.71
Quick ratioThe same, excluding inventory.
1.53
Debt to equityTotal borrowings against shareholders’ equity.
0.91
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-1.43
Book value per shareShareholders’ equity divided by shares outstanding.
$12.27
Shares outstandingShares currently issued.
95,976,406
Market capitalisationShare price times shares outstanding.
$983.76M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
142
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
What is Meribank Biotech Co., Ltd's return on equity?
Meribank Biotech Co., Ltd (4724.TWO) reports a return on equity of -11.33%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Meribank Biotech Co., Ltd carry?
Meribank Biotech Co., Ltd (4724.TWO) has a debt-to-equity ratio of 0.91, which compares total borrowings with shareholders' equity.
What is Meribank Biotech Co., Ltd's profit margin?
Meribank Biotech Co., Ltd (4724.TWO) keeps -33.07% of revenue as net profit after every cost, including tax and interest.